4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001415889-23-002604
EVP, CHIEF SCIENTIFIC OFFICER sold 2,790 shares at $9.67 ($26,966)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | 2023-02-13 | Sale | −2,790 | $9.67 | $26,966 | 65,559 | D |
| Open-market sales · 2,790 sh · avg $9.67 · $26,966 | |||||||
Loading xslF345X03/form4-02152023_040213.xml…